Swedbank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Swedbank’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,002	Closed	-$731K	–	674
2025 Q1	$731K	Sell	3,002 -1,858	-38%	-$559K	﹤0.01%	668
2024 Q4	$1.6M	Hold	4,860	–	–	﹤0.01%	638
2024 Q3	$1.63M	Sell	4,860 -414	-8%	-$131K	﹤0.01%	626
2024 Q2	$1.44M	Hold	5,274	–	–	﹤0.01%	629
2024 Q1	$1.82M	Hold	5,274	–	–	﹤0.01%	611
2023 Q4	$1.7M	Hold	5,274	–	–	﹤0.01%	608
2023 Q3	$1.89M	Hold	5,274	–	–	﹤0.01%	592
2023 Q2	$2M	Sell	5,274 -38,000	-88%	-$15.5M	﹤0.01%	593
2023 Q1	$20.7M	Sell	43,274 -9,800	-18%	-$4.59M	0.04%	304
2022 Q4	$22.3M	Buy	53,074 +3,500	+7%	+$1.41M	0.05%	288
2022 Q3	$20.7M	Buy	49,574 +7,200	+17%	+$3.59M	0.05%	296
2022 Q2	$21M	Buy	42,374 +300	+0.7%	+$156K	0.05%	288
2022 Q1	$23.7M	Hold	42,074	–	–	0.04%	302
2021 Q4	$31.9M	Hold	42,074	–	–	0.05%	267
2021 Q3	$31.4M	Hold	42,074	–	–	0.06%	263
2021 Q2	$27.1M	Buy	42,074 +9,800	+30%	+$5.96M	0.05%	286
2021 Q1	$18.4M	Buy	+32,274	New	+$19.1M	0.04%	349

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

FPA

First Pacific Advisors El Segundo, California $8.09B AUM 21.95% 1-Year Est. Return

Swedbank's BIO Position: Q2 2025 in Review

Swedbank sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 3,002 shares — an estimated $731K sold.

Swedbank first reported a position in BIO in Q1 2021 and held it in 17 quarters. The position peaked at $31.9M in Q4 2021. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

Swedbank reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
Swedbank sold 3,002 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $731K.
Swedbank first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 17 quarters.
Swedbank's Bio-Rad Laboratories Class A position peaked at $31.9M in Q4 2021.
384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Swedbank's 13F filing for Q2 2025, filed 10 Jul 2025.